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Abstract: The objective of this study was to investigate the influence of oral
contraceptives on the incidence rate of alveolar osteitis (AO) following the
surgical extraction of both impacted mandibular third molars. This
retrospective study reviewed the clinical records of patients who presented to
the oral surgery clinic of a university school of dentistry for the extraction of
impacted mandibular third molars. Using a database search, all patients were
categorized by sex, age, occurrence of AO, and whether the females were
taking oral contraceptives at the time of surgery. The patient was considered
positive for AO if either one or both sockets developed AO. The incidence of
AO among women taking oral contraceptives at the time of impacted
mandibular third molar extraction differed significantly from that in the other
patient groups. AO occurred in 37.9% (11/29) of females taking oral
contraceptives, while only 8.9% (16/179) of females who were not taking oral
contraceptives at the time of extraction developed AO. The total incidence of
AO among females was 13.0% (27/208). The total incidence of AO among the
363 males and females presenting for mandibular third molar extractions was
13.8%. Females who are taking oral contraceptives at the time of impacted
mandibular third molar extraction are at a higher risk of developing AO
following extraction.
Key words: wisdom teeth, osteitis, oral contraceptives, infection

The most common complication following the extraction of teeth
is alveolar osteitis (AO).1 ‘Dry socket’ is another term used to describe
this complication. The term dry socket was first used by Crawford in
1896, and since that time it has been given several other names,
including fibrinolytic alveolitis, postoperative alveolitis, localized
osteomyelitis, fibrinolytic alveolitis, and delayed extraction wound
healing.2 AO is a complication seen in 0.5–5% of routine extractions. It
has been reported to occur more often following the extraction of
impacted mandibular third molars. Studies have reported incidence
rates as high as 37.5% following the surgical extraction of impacted
lower third molars.3
AO presents when the blood clot in the extraction site is
prematurely disrupted and/or removed. This leaves the underlying
bone unprotected and exposed to the oral environment.4 Bacterial
contamination has been suggested as a major etiological factor.5 The
fibrinolytic system can also cause fibrinolysis of the clot. Factors such
as physical and mental stress, severity of the surgical procedure, and
the type of tissue operated on can result in increased fibrinolytic
activity.6 Other factors may also play a role in the development of AO.
Intraoperative complications such as root fracture, alveolar bone
fracture, or fragments from the tooth or alveolar bone remaining after
the surgery may also result in AO.
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There is no clear or proven aetiology for the development of AO,
but many risk factors have been identified. These include the patient's
sex,7 the use of oral contraceptives,8 smoking,9 patient age,10 difficulty
of the extraction,11 surgeon's experience,12 preoperative infection,13
and the menstrual cycle.14 and 15 Signs and symptoms of AO often
develop within 1–3 days following surgery. The signs and symptoms
include but are not limited to pain, sensitivity to gentle probing, foul
taste, halitosis, localized swelling, and lymph node involvement.16
The purpose of the present study was to investigate the
influence of oral contraceptives on the incidence rate of AO following
the surgical extraction of both impacted mandibular third molars. It
was hypothesized that the incidence rate of AO would be higher among
female patients taking oral contraceptives at the time of their surgery
as compared to females not taking oral contraceptives. Comparisons
were also made with all other patients presenting for the extraction of
impacted mandibular third molars.

Materials and methods
A total of 363 patients aged 14–78 years presented to the oral
surgery clinic of a university school of dentistry for the extraction of
full bony impacted mandibular third molars. The mean ± standard
deviation age of all patients presenting for surgery was 26.7 ± 11.16
years. Of the total group of patients, 179 were females not taking oral
contraceptives at the time of surgery (average age 24.5 ± 9.23 years)
and 29 were females who reported using oral contraceptives at the
time of surgery (average age 25.6 ± 7.18 years). All patients had both
mandibular third molars extracted. The patients were considered
positive for AO if they developed AO in either one or both extraction
sockets.
Two oral surgeons performed all extractions. Every surgery was
for the extraction of full bony impacted mandibular third molars. The
surgeries varied in difficulty with regard to the full bony impaction. All
surgeries required bone removal and tooth section, which were
performed with an electric hand-piece. All patients received the same
care; they were given the same postoperative medications and
instructions. Standard postoperative instructions were provided and
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the patients were instructed to return to the clinic if they experienced
any irregular healing, swelling, and/or pain.
A search of the dental records database (axiUm; Exan Group,
Coquitlam, BC, Canada) was conducted to identify patients who had
returned to the clinic presenting with AO. A search using the following
key words was performed in the treatment notes: “dry socket”,
“alveolar osteitis”, “infection”, “dressing”, “pain”, and “halitosis”. All
treatment notes that included any of the key words were reviewed to
confirm that the patient had presented postoperatively with AO.
“Infection” was included as a key word so that the patient's treatment
notes could be read to determine if they had presented to the clinic
with a postoperative infection or AO. Patient exclusion criteria included
the use of immunosuppressive agents and/or antibiotics, an
immunocompromised status, smoking habit, and diagnosis with a
postoperative infection.

Results
The incidence of AO among females taking oral contraceptives
at the time of impacted mandibular third molar extraction differed
significantly from that in the other patient groups. As shown in Table 1
and Fig. 1, AO occurred in 37.9% (11/29) of the females taking oral
contraceptives, while only 8.9% (16/179) of females who were not
taking oral contraceptives at the time of extraction developed AO.
Table 1. Incidence of alveolar osteitis and use of oral contraceptives.
Not taking oral
contraceptives
No alveolar
osteitis

163

Alveolar osteitis 16
Total

179

Taking oral
contraceptives

Total

18

181

11

27

29

208
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Fig. 1. Incidence of alveolar osteitis and use of oral contraceptives.

The total incidence of AO among females was 13.0% (27/208).
A similar result was found among male patients, who presented an
incidence of AO of 14.8% (23/155). The total incidence of AO among
the 363 males and females presenting for mandibular third molar
extractions was 13.8% (n = 50) (Table 2, Fig. 2).
Table 2. Incidence of alveolar osteitis in males compared to females.
Male
No alveolar osteitis
Alveolar osteitis
Total

Female

Total

132

181

313

23

27

50

155

208

363

Fig. 2. Incidence of alveolar osteitis in males compared to females.
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Pearson's χ2 test was used to compare the data. The difference
in incidence of AO between women taking oral contraceptives at the
time of extractions and women not taking oral contraceptives was
found to be statistically significant (P < 0.01). Furthermore, the
difference in incidence of AO between women taking oral
contraceptives at the time of extractions and men was also found to be
statistically significant (P < 0.001).

Discussion
The most common postoperative complication of surgical
removal of impacted mandibular third molars is AO, due to fibrinolysis
of the clot. The incidence of AO among women began to increase in
the 1960s as oral contraceptives came into more widespread use. In
1974, Schow found the incidence rate of AO to be 45% among women
taking oral contraceptives, compared to only 17% among women not
taking oral contraceptives.14 The higher incidence of AO can be
attributed to the increased fibrinolysis caused by the use of oral
contraceptives.
The majority of the more recent studies have supported the
conclusions reached by earlier studies. These studies have concluded
that oral contraceptive use is a risk factor for AO following the surgical
removal of impacted mandibular third molars. There are a few studies
that did not find a statistical difference between women taking and not
taking oral contraceptives. It should be noted that many of these
studies had a relatively small sample size.
The results from this study support previous findings; the use of
oral contraceptives at the time of mandibular third molar extraction
will increase the risk of developing AO following surgery. This study
found that there was an approximately 3.5-times greater risk of
developing AO if the female patient was taking oral contraceptives at
the time of surgery. The incidence rates of AO in the oral contraceptive
and non-oral contraceptive groups in the present study were similar to
those reported in many other related studies.
Due to the retrospective nature of this study, the results are
reliant on the accurate postoperative diagnosis of AO by the oral
surgeons. The description of AO is diverse and it is sometimes difficult
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to diagnose consistently. Therefore, this study was limited because it
was not possible to establish specific criteria for the diagnosis of AO.
Due to the nature of third molar impactions, there is great variability
in the extraction procedure. To overcome this problem, all surgeries
that had complications or were deemed unusually difficult were
excluded. Additionally, mandatory follow-up of the patients was not
required. Therefore, it is possible that some patients developed AO but
did not report their symptoms to the dental school.
The majority of studies on the subject have found that oral
contraceptive use increases the incidence rate of AO. Eshghpour et al.
examined the menstrual cycle status of patients as a possible risk
factor for AO. They found that the frequency of AO in women in the
middle of their menstrual cycle was significantly greater than that in
women during the menstrual period for both oral contraceptive users
and non-users.15 Although there is significant evidence, more specific
studies relating the incidence rates of AO to specific days of the female
menstrual cycle are required to gain a better understanding of the role
of oral contraceptives and oestrogen in the development of AO. Also,
additional studies are needed to examine the different types of oral
contraceptives and to determine the actual hormone levels at the time
of surgery.
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